Amyris is a California-based synthetic biotechnology company that converts plant sugar into hydrogen molecules to produce nutraceutical, beauty and wellness products.
Business Model:
Revenue: $222.7M
Employees: 501-1,000
Address: 5885 Hollis Street
City: Emeryville
State: CA
Zip: 94608
Country: US
Amyris is a California-based synthetic biotechnology company that converts plant sugar into hydrogen molecules to produce nutraceutical, beauty and wellness products.
Contact Phone:
+15104500761
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/28/2010
IPO Valuation:
$650M
Ticker Symbol:
AMRS
IPO Price:
$16/share
Amount Raised:
$85M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
1/2022 | MenoLabs | |
8/2021 | MG Empower | |
6/2021 | OLIKA | |
4/2021 | Beauty Labs | |
3/2021 | Costa Brazil | |
11/2011 | Draths Corporation |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|